According to a study, there is an increased risk of diabetes in later life if one or more servings of sugary soft drinks are consumed on a daily basis.
The chance of the risk of diabetes increasing with a can of soft drink is about a fifth when compared with just one can being consumed in a month, according to European scientists.
Recommendations from a diabetes charity state that sugary foods and drinks should be avoided as they increase weight and are calorific.
Countries that saw the latest research being carried out were UK, Germany, Denmark, Italy, Spain, Sweden, France and the Netherlands.
Questions about diet were put up to about 350,000 individuals. Through this, the researchers were trying to look at links between diet and cancer.
Lead researcher Dora Romaguera from Imperial College London said, "The consumption of sugar sweetened soft drinks increases your risk of diabetes - so for every can of soft drinks that you drink per day, the risk is higher."
She stated that the public should have a more clear picture of the health information related to the effects of sugary soft drinks.
In a recent announcement, Sega has revealed that its Steam catalog of classic Genesis and Mega Drive games is being updated with a new 3D interface --- the Sega Mega Drive Classics Hub.
Announcing the Classics Hub, Sega said that the new...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Wednesday, European competition authorities unveiled...
The button white mushroom edited using CRISPR has...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).